Redefining Neuro-Ophthalmology

Neuro-ophthalmologists are redefining their role in diagnosing and treating neurodegenerative diseases by utilizing advanced imaging technology that connects the retina to the brain. This shift emphasizes the retina as a source of crucial diagnostic information, revolutionizing how conditions like Parkinson's, Alzheimer's, and multiple sclerosis are monitored and treated. Utilizing innovations such as fluorescence lifetime imaging ophthalmoscopy (FLIO), researchers are uncovering metabolic changes that predate structural damage. Collaborative efforts aim to integrate patient findings with scientific research, paving the way for personalized medicine and innovative therapies.

About the Author(s)

Robert C. Sergott

Robert C. Sergott, MD, is Chief of the Wills Eye Neuro-Ophthalmology Service and Founding Director of the Annesley EyeBrain Center at Thomas Jefferson University in Philadelphia. He is also the Margaret and Richard Hayne Distinguished Professor of Ophthalmology at Jefferson. Dr. Sergott has served as a consultant for Heidelberg Engineering. He may be reached at robert.sergott@jefferson.edu or rsergott@willseye.org.

More Articles by Robert C. Sergott